newsfilter
← Latest News
Business Wire·

The FDA Approves IDE for ReGelTec's Pivotal Study of HYDRAFIL® for Chronic Low Back Pain due to Degenerative Disc Disease

ReGelTec, Inc., announced that the U.S. Food and Drug Administration has approved an IDE for the company's pivotal study to support premarket approval of its HYDRAFIL® System. The HYDRAFIL System contains an